Sweet's syndrome and Pneumocystis carinii pneumonia: Two sequelae of low-dose cytosine arabinoside therapy in a patient with acute myeloid leukemia

V. Chowdhary, S. Nityanand, K. N. Prasad, R. Pandey, S. Dabadghao

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Abstract

Cytosine arabinoside in low dose is sometimes employed for treating acute myeloid leukaemia. We report here a case of acute myeloid leukemia, treated with low-dose cytosine arabinoside, who developed acute febrile neutrophilic dermatosis and Pneumocytsis carinii pneumonia after attainment of remission. A direct effect of cytosine arabinoside on neurophil function and an immunosuppressive potential in lower doses could be speculated.

Original languageEnglish (US)
Pages (from-to)72-73
Number of pages2
JournalEuropean Journal of Haematology
Volume65
Issue number1
DOIs
StatePublished - 2000

Keywords

  • Low-dose cytosine arabinoside
  • Pneumocystis carinii pneumonia
  • Sweet's syndrome

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Sweet's syndrome and Pneumocystis carinii pneumonia: Two sequelae of low-dose cytosine arabinoside therapy in a patient with acute myeloid leukemia'. Together they form a unique fingerprint.

Cite this